Uloric, a doctor prescribed remedy to treat cases of gout, is a xanthine oxidase inhibitor. It generally stops gout attacks from occurring if used over a certain period of time and if it functions how it is intended to. However, Uloric is now under a recall request that was put in place by the FDA in response to a study in which the results have shown a link between the drug and the potential for cardiac death.
The newfound dangers of the drug reflect this added risk to the packaging, which has been updated. Attorneys are now determining if a Uloric lawsuit against the manufacturer of the drug is viable based on the claim that the drug is defective.